Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial
      QxMD   Google Scholar   
Citation:
Clin. Cancer Res. vol 19 (17) 4816-23
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Book Volume:
3
Parents:
406   590   639   640  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                         
Networks:
 
Study
NCCTG-N0776
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: